These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16611090)

  • 41. Only arginine vasopressin, not oxytocin and endogenous opiate peptides, in hypothalamic paraventricular nucleus play a role in acupuncture analgesia in the rat.
    Yang J; Liu WY; Song CY; Lin BC
    Brain Res Bull; 2006 Feb; 68(6):453-8. PubMed ID: 16459202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival.
    Mohan S; Moffett RC; Thomas KG; Irwin N; Flatt PR
    Biochimie; 2019 Mar; 158():191-198. PubMed ID: 30677431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats.
    Zelena D; Filaretova L; Mergl Z; Barna I; Tóth ZE; Makara GB
    Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E243-50. PubMed ID: 16144820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion.
    Wotjak CT; Ludwig M; Ebner K; Russell JA; Singewald N; Landgraf R; Engelmann M
    Eur J Neurosci; 2002 Aug; 16(3):477-85. PubMed ID: 12193191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides.
    Bhargava A; Dallman MF; Pearce D; Choi S
    Brain Res Brain Res Protoc; 2004 Jun; 13(2):115-25. PubMed ID: 15171994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blunted HPA axis reactivity reveals glucocorticoid system dysbalance in a mouse model of high anxiety-related behavior.
    Sotnikov S; Wittmann A; Bunck M; Bauer S; Deussing J; Schmidt M; Touma C; Landgraf R; Czibere L
    Psychoneuroendocrinology; 2014 Oct; 48():41-51. PubMed ID: 24995583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opposite effects of central oxytocin and arginine vasopressin on changes in gastric motor function induced by chronic stress.
    Bülbül M; Sinen O; Gemici B; İzgüt-Uysal VN
    Peptides; 2017 Jan; 87():1-11. PubMed ID: 27829122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific expression of optically active reporter gene in arginine vasopressin-secreting neurosecretory cells in the hypothalamic-neurohypophyseal system.
    Ueta Y; Fujihara H; Dayanithi G; Kawata M; Murphy D
    J Neuroendocrinol; 2008 Jun; 20(6):660-4. PubMed ID: 18601686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapituitary expression of the rat V1b vasopressin receptor gene.
    Lolait SJ; O'Carroll AM; Mahan LC; Felder CC; Button DC; Young WS; Mezey E; Brownstein MJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6783-7. PubMed ID: 7624319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety.
    Landgraf R; Wigger A
    Behav Genet; 2002 Sep; 32(5):301-14. PubMed ID: 12405513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central vasopressin and oxytocin release: regulation of complex social behaviours.
    Veenema AH; Neumann ID
    Prog Brain Res; 2008; 170():261-76. PubMed ID: 18655888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous vasopressin, innate anxiety, and the emission of pro-social 50-kHz ultrasonic vocalizations during social play behavior in juvenile rats.
    Lukas M; Wöhr M
    Psychoneuroendocrinology; 2015 Jun; 56():35-44. PubMed ID: 25800147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats.
    Keck ME; Hatzinger M; Wotjak CT; Landgraf R; Holsboer F; Neumann ID
    Eur J Neurosci; 2000 Apr; 12(4):1487-94. PubMed ID: 10762376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic DNA methylation programs persistent adverse effects of early-life stress.
    Murgatroyd C; Patchev AV; Wu Y; Micale V; Bockmühl Y; Fischer D; Holsboer F; Wotjak CT; Almeida OF; Spengler D
    Nat Neurosci; 2009 Dec; 12(12):1559-66. PubMed ID: 19898468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasopressin V1a and V1b receptors: from molecules to physiological systems.
    Koshimizu TA; Nakamura K; Egashira N; Hiroyama M; Nonoguchi H; Tanoue A
    Physiol Rev; 2012 Oct; 92(4):1813-64. PubMed ID: 23073632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.